medicare and semaglutide launches weight loss drug option with $50 copay : NPR Trump says GLP-1 weight-loss drugs

However, when looking at costs by weight lost, Mounjaro has a slim advantage

PepScribe is a LegitScript-certified telehealth practice

O uso destes novos medicamentos (liraglutida, semaglutida e tirzepatida), com consequente reduo do apetite e lentificao do esvaziamento gstrico, podem desencadear ou at agravar as deficincias nutricionais, uma vez que a ingesta alimentar estar consideravelmente reduzida e, na maioria das vezes, a dieta no ser equilibrada (a maior palatabilidade de alimentos ricos em gorduras e carboidratos contribui para o desequilbrio habitualmente visto na populao)

But as a scientist, I would not advise prescribing [GLP-1s] for the sole indication of addiction at this point, pending more studies and understanding, and more resolution of uncertainties. Still, the data are the first step in understanding a potentially powerful new way these medications could be used to address another significant health issue that so far hasnt enjoyed truly effective prevention and treatment strategies

Eli Lilly has also issued its own stark warning

Thus, the next generation of PSR-MNs could be developed as a CGMS and as a continuous real time multi-analyte release platform in general, with the addition of lactate and ketone sensing capabilities